Olanzapine augmentation for treatment-resistant obsessive-compulsive disorder
about
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Posttraumatic Stress DisordersCurrent and potential pharmacological treatments for obsessive-compulsive disorderSecond-generation antipsychotics for obsessive compulsive disorderPharmacotherapy augmentation strategies in treatment-resistant anxiety disordersQuetiapine augmentation of SRIs in treatment refractory obsessive-compulsive disorder: a double-blind, randomised, placebo-controlled study [ISRCTN83050762]Off-label indications for atypical antipsychotics: A systematic reviewThe role of atypical antipsychotics in bipolar depression and anxiety disordersMore than Medication-Achieving Goals through Psychotherapy in Patients with Obsessive Compulsive Disorder.Psychopharmacology of anxiety disorders.Clinical treatment of obsessive compulsive disorderWorld Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders - first revision.Aripiprazole augmentation in patients with resistant obsessive compulsive disorder: a pilot study.Current management of obsessive and phobic states.The selective serotonin reuptake inhibitor, escitalopram, enhances inhibition of prepotent responding and spatial reversal learningObsessive-compulsive disorder: a critical review of therapeutic perspectives.Antipsychotic treatment in obsessive-compulsive disorder: a literature review.A review of antipsychotics in the treatment of obsessive compulsive disorder.Role of dopamine in the pathophysiology and treatment of obsessive-compulsive disorder.Augmentation strategies in obsessive-compulsive disorder.Second generation antipsychotic-induced obsessive-compulsive symptoms in schizophrenia: a review of the experimental literature.Olanzapine augmentation of serotonin uptake inhibitors in obsessive-compulsive disorder: an open study.Efficacy of olanzapine augmentation of paroxetine therapy in patients with severe body dysmorphic disorder.Augmentation strategy with olanzapine in resistant obsessive compulsive disorder: an Italian long-term open-label study.The Black Book of Psychotropic Dosing and Monitoring.Bipolar disorder and comorbid obsessive-compulsive disorder is associated with higher rates of anxiety and impulse control disorders.Critical Review of the Use of Second-Generation Antipsychotics in Obsessive-Compulsive and Related Disorders
P2860
Q22305681-BB6F13D8-8DE0-4A84-9CB1-A633D9115531Q22306025-07A665DA-C614-4E6F-A25D-A4EDBA818B87Q24235770-4CEEDB5E-1A72-421D-9975-2BE9A914C8EEQ24243827-FEE24096-811B-4941-A581-F546656A37B6Q24798724-3014E0AF-DF86-4A66-AEFD-92468B25E3D6Q24803302-1CE310D1-D818-438C-BCAC-D8C465548067Q28236713-1995397C-1C0B-42B7-BCFA-B84A9CD5ABEDQ34068960-0D86960F-AA6B-43EF-BD06-03F8F5BE5149Q34228150-4BF577D3-C246-4505-A880-CA1E46866C68Q34359796-E739CD46-8CF7-41CD-B034-84B1A0CC5221Q34865036-7BCB564B-635B-4C56-A77A-3F7525913D98Q35047082-457B2D28-52F6-418E-AE45-8610C75721C8Q35327098-A038D771-710F-4397-9F96-D7C857D804AFQ35937022-6280B3BE-2D8A-40B2-8931-DE0E3BE454FFQ36058933-5C7B012C-F5EF-4BA4-8D0B-1C5EEB195C8FQ36110049-6B061853-81B1-4743-AD2E-2D433508B92EQ36276544-928D46FA-4FEC-4042-A565-E81CC6DCB9D7Q37688083-24D06C62-0ED5-4C55-866F-3824BE11FE1DQ38078029-575EDADE-67B8-49B1-A75C-DD59A14C44F6Q38254316-51619E91-26F7-437C-BE92-549D68321A4FQ43626940-6D823AF3-52A5-4F6E-85AA-2BC01206C6FAQ46512031-D2A3F53F-4EB0-48E8-83EE-8ACC2A59A145Q46570346-13BF7F1E-86E3-42AF-A712-E54B48CB788AQ47642128-029E3802-66A1-4C93-A9B2-C43A3FDF1BF3Q51574185-CF575710-00CA-4392-A7C7-A48CBB722B58Q58780376-06B93789-7B78-4AFF-9184-C3EE96200237
P2860
Olanzapine augmentation for treatment-resistant obsessive-compulsive disorder
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Olanzapine augmentation for treatment-resistant obsessive-compulsive disorder
@ast
Olanzapine augmentation for treatment-resistant obsessive-compulsive disorder
@en
Olanzapine augmentation for treatment-resistant obsessive-compulsive disorder
@nl
type
label
Olanzapine augmentation for treatment-resistant obsessive-compulsive disorder
@ast
Olanzapine augmentation for treatment-resistant obsessive-compulsive disorder
@en
Olanzapine augmentation for treatment-resistant obsessive-compulsive disorder
@nl
prefLabel
Olanzapine augmentation for treatment-resistant obsessive-compulsive disorder
@ast
Olanzapine augmentation for treatment-resistant obsessive-compulsive disorder
@en
Olanzapine augmentation for treatment-resistant obsessive-compulsive disorder
@nl
P2093
P356
P1476
Olanzapine augmentation for treatment-resistant obsessive-compulsive disorder
@en
P2093
A L Ringold
M A Elliott
P356
10.4088/JCP.V61N0709
P407
P577
2000-07-01T00:00:00Z